Danimer Scientific

Danimer Scientific Stock Forecast & Price Prediction

Live Danimer Scientific Stock (DNMR) Price
$10.78

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$10.78

P/E Ratio

-6.54

Volume Traded Today

$427,867

Dividend

Dividends not available for DNMR

52 Week High/low

18.36/0.29

Danimer Scientific Market Cap

$30.2M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $DNMR ๐Ÿ›‘

Before you buy DNMR you'll want to see this list of ten stocks that have huge potential. Want to see if DNMR made the cut? Enter your email below

DNMR Summary

From what 0 stock analysts predict, the share price for Danimer Scientific (DNMR) might decrease by 92.58% in the next year. This is based on a 12-month average estimation for DNMR. Price targets go from $0.4 to $1. The majority of stock analysts believe DNMR is a sell. Please note analyst price targets are not guaranteed and could be missed completely.

DNMR Analyst Ratings

About 0 Wall Street analysts have assignedDNMR 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Danimer Scientific to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on DNMR. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

DNMR stock forecast by analyst

These are the latest 20 analyst ratings of DNMR.

Analyst/Firm

Rating

Price Target

Change

Date

Charles Neivert
Piper Sandler

Neutral

$1

Maintains

Aug 21, 2024

TD Cowen

Hold


Downgrade

Aug 13, 2024
Laurence Alexander
Jefferies

Hold

$0.8

Downgrade

May 22, 2024
Charles Neivert
Piper Sandler

Neutral

$1.25

Downgrade

Apr 9, 2024
Thomas Boyes
TD Cowen

Buy

$2

Maintains

Apr 4, 2024
Charles Neivert
Piper Sandler

Overweight

$4

Maintains

Oct 11, 2023
Charles Neivert
Piper Sandler

Overweight

$8

Maintains

Jun 1, 2023
Charles Neivert
Piper Sandler

Overweight

$7

Maintains

Apr 3, 2023
Charles Neivert
Piper Sandler

Overweight

$4.5

Initiates

Oct 12, 2022
Thomas Boyes
Cowen & Co.

Outperform

$21

Initiates

Sep 23, 2021

DNMR Company Information

What They Do: Produces biodegradable bioplastics as alternatives.

Business Model: The company generates revenue by manufacturing and selling bioplastic materials, such as polyhydroxyalkanoate and polylactic acid-based resins, to various industries including consumer packaging and manufacturing. Its focus on biodegradable solutions positions it to capitalize on the growing demand for sustainable materials.

Other Information: Founded in 2004 and headquartered in Bainbridge, Georgia, the company operates in multiple international markets, including the United States and Europe. Its innovative products cater to a wide range of applications, addressing the need for eco-friendly alternatives in the plastics industry.
DNMR
Danimer Scientific (DNMR)

When did it IPO

2012

Staff Count

257

Country

United States

Sector/Industry

Basic Materials/Specialty Chemicals

CEO

Mr. Stephen E. Croskrey

Market Cap

$30.2M

Danimer Scientific (DNMR) Financial Data

In 2023, DNMR generated $46.7M in revenue, which was a decrease of -12.28% from the previous year. This can be seen as a signal that DNMR's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$47.3M

Revenue From 2021

$58.7M

24.12 %
From Previous Year

Revenue From 2022

$53.2M

-9.41 %
From Previous Year

Revenue From 2023

$46.7M

-12.28 %
From Previous Year
  • Revenue TTM $39.7M
  • Operating Margin TTM -246.0%
  • Gross profit TTM $-26,960,000
  • Return on assets TTM -8.8%
  • Return on equity TTM -45.9%
  • Profit Margin -57.7%
  • Book Value Per Share 2.01%
  • Market capitalisation $30.2M
  • Revenue for 2021 $58.7M
  • Revenue for 2022 $53.2M
  • Revenue for 2023 $46.7M
  • EPS this year (TTM) $-48.41

Danimer Scientific (DNMR) Latest News

News Image

Fri, 01 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Danimer Scientific, Inc. will implement a 1-for-40 reverse stock split for its Class A common stock, following approval from stockholders and its Board of Directors.

Why It Matters - The reverse stock split indicates a restructuring effort, potentially aimed at increasing share price and attracting institutional investors, impacting liquidity and market perception.

News Image

Mon, 28 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Danimer Scientific's putative class action complaint was dismissed by the U.S. Court of Appeals for the Second Circuit, affirming a 2023 District Court ruling.

Why It Matters - The court's dismissal of the class action lawsuit reduces legal risks for Danimer Scientific, potentially stabilizing its stock and attracting investor confidence in its bioplastics business.

News Image

Tue, 15 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Danimer Scientific has appointed Richard Altice as Interim CEO, succeeding Stephen Croskrey, who is retiring. Altice is a current director and former CEO of NatureWorks.

Why It Matters - Leadership changes can impact a company's strategic direction and operational performance, influencing investor confidence and stock prices.

News Image

Tue, 24 Sep 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Danimer Scientific (NYSE: DNMR) received a $1.36 million award from the U.S. Department of Defense to develop a facility for producing biobased polyols for high-performance coatings.

Why It Matters - Danimer Scientific's $1.36 million award from the U.S. Department of Defense enhances its credibility and funding, potentially boosting revenue and market position in biomaterials.

News Image

Thu, 26 Sep 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Danimer Scientific (NYSE: DNMR) and Ningbo Homelink have launched home compostable coatings made from Danimer's PHA, Nodaxยฎ, for disposable tableware.

Why It Matters - The launch of home compostable biopolymers by Danimer and Homelink signals growing demand for sustainable products, potentially enhancing market share and revenue, which can positively impact stock performance.

News Image

Wed, 14 Aug 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - Danimer Scientific (DNMR) has received a Zacks Rank #2 (Buy), indicating increasing optimism about its earnings prospects, which may lead to potential stock price growth.

Why It Matters - The upgrade to Zacks Rank #2 indicates positive sentiment around Danimer Scientific's earnings, suggesting potential stock price appreciation and increased investor confidence.

...

DNMR Frequently asked questions

The highest forecasted price for DNMR is $1 from Charles Neivert at Piper Sandler.

The lowest forecasted price for DNMR is $0.4 from from

The DNMR analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.